Nature Clinical Practice Oncology

Title Publication Date Language Citations
Drug Insight: role of the androgen receptor in the development and progression of prostate cancer2007/04/01English130
Mechanisms of Disease: cancer stem cells—targeting the evil twin2008/04/22English129
Serrated adenoma of the colorectum and the DNA-methylator phenotype2005/08/01English127
Drug Insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms2006/07/01English125
The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER22008/07/08English122
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS2008/07/29English120
Mechanisms of Disease: temozolomide and glioblastoma—look to the future2008/06/10English117
Origins of breast cancer subtypes and therapeutic implications2007/09/01English117
Perspectives in the treatment of gastric cancer2005/02/01English114
Angiogenesis as a strategic target for ovarian cancer therapy2008/02/12English109
Will focal therapy become a standard of care for men with localized prostate cancer?2007/11/01English109
Advances in the systemic therapy of malignant pleural mesothelioma2008/01/29English109
Cancer chemoprevention: scientific promise, clinical uncertainty2005/10/01English106
Mechanisms of Disease: inflammatory mediators and cancer prevention2005/04/01English105
Mechanisms of Disease: angiogenesis and the management of breast cancer2007/09/01English103
Prognostic false-positivity of the sentinel node in melanoma2008/01/01English102
Mechanisms of Disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis2006/01/01English101
Surgery Insight: radical vaginal trachelectomy as a method of fertility preservation for cervical cancer2007/06/01English98
Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology: tools or decorations?2008/06/17English98
Technology Insight: identification of biomarkers with tissue microarray technology2004/12/01English96
Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutation2006/01/01English94
Rapamycin treatment for a child with germline PTEN mutation2008/04/22English93
Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy2006/11/01English92
Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies2006/07/01English89
Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease2007/01/01English88
In silico cancer modeling: is it ready for prime time?2008/10/14English88
Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions2007/03/01English88
Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome2007/10/01English86
Why does cytotoxic chemotherapy cure only some cancers?2008/11/04English84
Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications2008/07/01English84